Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07286266 |
| Title | A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01) |
| Acronym | BEHOLD-Ovarian01 |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | RECRUITING | Randwick | New South Wales | 2031 | Australia | Details |
| GSK Investigational Site | RECRUITING | Montreal | Quebec | H2X 0C1 | Canada | Details |
| GSK Investigational Site | RECRUITING | Montreal | Quebec | H4A 3J1 | Canada | Details |
| GSK Investigational Site | RECRUITING | Hyōgo | 673-8558 | Japan | Details | |
| GSK Investigational Site | RECRUITING | Osaka | 569-8686 | Japan | Details |